CGP-75355
CGP-75355 is an inhibitor of HIV-1 protease with IC50 of 26 nM. CGP-75355 is a bis(L-tert-leucine) derivative.
For research use only. We do not sell to patients.
- CAS No.: 191594-64-6
- Formula: C39H53N5O7
- Molecular Weight:703.87
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MT2 | ED50 |
0.7 nM
Compound: 25a
|
Concentration required to inhibit 50% of RT production in HIV-1/MN-infected MT-2 cells.
Concentration required to inhibit 50% of RT production in HIV-1/MN-infected MT-2 cells.
|
[PMID: 9719591] |
| MT2 | IC50 |
58 nM
Compound: 25a
|
The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.
The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.
|
[PMID: 9719591] |
Chemical Information
-
CAS No. 191594-64-6
-
Molecular Weight 703.87
-
Formula C39H53N5O7
-
SMILES
CC(C)(C)[C@@H](C(N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(NC([C@H](C(C)(C)C)NC(OC)=O)=O)CC2=CC=C(C3=CC=CC=C3)C=C2)=O)NC(OC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Bold, G., et al., (1998). New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development. Journal of medicinal chemistry, 41(18), 3387-3401. [Content Brief]
[2]. Wieslaw M. Kazmierski, (2011). Antiviral Drugs: From Basic Discovery Through Clinical Trials.
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)